IDEXX Labs (IDXX) Tops Q3 EPS by 8c; Raises FY18 EPS Outlook, Maintains FY18 Revenue Guidance, Offers Prelim. FY19 EPS/Revenue Views

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. DOL:CN

Go back to IDEXX Labs (IDXX) Tops Q3 EPS by 8c; Raises FY18 EPS Outlook, Maintains FY18 Revenue Guidance, Offers Prelim. FY19 EPS/Revenue Views

IDEXX Laboratories Announces Third Quarter Results

November 1, 2018 6:30 AM EDT

WESTBROOK, Maine, Nov. 1, 2018 /PRNewswire/ -- 

Reports revenue growth of 11% on a reported basis and 12% on an organic basis, driven by CAG Diagnostics recurring revenue growth of 12% reported and 13% organic   Delivers EPS of $1.05, a 33% increase year-over-year on a reported basis or 39% on a comparable constant currency basis Refines 2018 reported revenue guidance to $2,205 billion - $2,215 billion, reflecting revenue growth of 12% - 12.5% on a reported basis and 11.5% - 12% on an organic basis Increases 2018 EPS guidance range to $4.16 - $4.21, $0.04 above the midpoint of prior guidance, reflecting higher expectations for 2018 share-based... More